Daniel D Burgess's Net Worth

$511 Thousand

Estimate Recalculated Apr 1, 2025 04:49PM EST

Who is Daniel D Burgess?

Daniel D Burgess does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Arbutus Biopharma Corp, Nabriva Therapeutics plc, Cidara Therapeutics, Inc., SANTARUS INC, METABASIS THERAPEUTICS INC, and HOLLIS EDEN PHARMACEUTICALS INC /DE/.

SEC CIK

Daniel D Burgess's CIK is 0001239650

Past Insider Trading and Trends

2013 was Daniel D Burgess's most active year for acquiring shares with 7 total transactions. Daniel D Burgess's most active month to acquire stocks was the month of May. 2013 was Daniel D Burgess's most active year for disposing of shares, totalling 11 transactions. Daniel D Burgess's most active month to dispose stocks was the month of December. 2018 saw Daniel D Burgess paying a total of $99,000.00 for 113,000 shares, this is the most they've acquired in one year. In 2014 Daniel D Burgess cashed out on 378,000 shares for a total of $9,712,840.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
No matching records found

Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Aug 17
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Mar 24
Form 3
—
0
—
—
0
No matching records found

Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-52.20%
-11.34K
$0.19
-$2,155.92
10.38K
Aug 2
Form 4
-4.92%
-1.13K
$1.20
-$1,350.00
21.73K
Aug 2
Form 4
+327.10%
17.5K
—
—
22.85K
Jul 28
Form 4
+48.61%
17.5K
—
—
53.5K
Jul 29
Form 4
—
0
—
—
0
Jul 31
Form 4
∞
36K
$2.75
$99,000.00
36K
Jul 31 - Aug 1
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
Sep 15
Form 3
—
0
—
—
0
No matching records found

Cidara Therapeutics, Inc. (CDTX) Snapshot price: $13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 18
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 9
Form 4
∞
3K
$16.00
$48,000.00
3K
Apr 20
Form 3
—
0
—
—
0
No matching records found

SANTARUS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
$12.17
-$146,726.40
0
Scheduled
Jun 3
Form 4
—
0
$10.44
-$119,047.20
0
Scheduled
May 1
Form 4
—
0
$9.78
-$123,053.60
0
Scheduled
Apr 1
Form 4
—
0
$7.28
-$97,513.60
0
Scheduled
Mar 1
Form 4
—
0
$7.23
-$96,804.80
0
Scheduled
Feb 1
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 9
Form 4/A
—
0
—
—
0
Jul 27
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found